190 related articles for article (PubMed ID: 33326835)
1. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.
Nimgaonkar I; Archer NF; Becher I; Shahrad M; LeDesma RA; Mateus A; Caballero-Gómez J; Berneshawi AR; Ding Q; Douam F; Gaska JM; Savitski MM; Kim H; Ploss A
Antiviral Res; 2021 Jan; 185():104997. PubMed ID: 33326835
[TBL] [Abstract][Full Text] [Related]
2. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis.
Qu C; Li Y; Li Y; Yu P; Li P; Donkers JM; van de Graaf SFJ; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2019 Oct; 170():104588. PubMed ID: 31415805
[TBL] [Abstract][Full Text] [Related]
3. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
4. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
5. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
6. Targeting proteostasis of the HEV replicase to combat infection in preclinical models.
Zhang F; Xu LD; Zhang Q; Wang A; Yu X; Liu S; Chen C; Wu S; Jin J; Lin A; Neculai D; Zhao B; Feng XH; Liang T; Xu P; Huang YW
J Hepatol; 2023 Apr; 78(4):704-716. PubMed ID: 36574921
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
8. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking.
Zheng ZZ; Miao J; Zhao M; Tang M; Yeo AE; Yu H; Zhang J; Xia NS
J Gen Virol; 2010 Jul; 91(Pt 7):1728-36. PubMed ID: 20219895
[TBL] [Abstract][Full Text] [Related]
9. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
[TBL] [Abstract][Full Text] [Related]
10. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
Debing Y; Winton J; Neyts J; Dallmeier K
Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Candidates for Treating Hepatitis E Virus Infection.
Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
[TBL] [Abstract][Full Text] [Related]
12. Screening of novel drugs for inhibiting hepatitis E virus replication.
Nishiyama T; Kobayashi T; Jirintai S; Kii I; Nagashima S; Prathiwi Primadharsini P; Nishizawa T; Okamoto H
J Virol Methods; 2019 Aug; 270():1-11. PubMed ID: 31004661
[TBL] [Abstract][Full Text] [Related]
13. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
[TBL] [Abstract][Full Text] [Related]
14. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targets for the treatment of hepatitis E virus infection.
Kenney SP; Meng XJ
Expert Opin Ther Targets; 2015; 19(9):1245-60. PubMed ID: 26073772
[TBL] [Abstract][Full Text] [Related]
17. Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.
Primadharsini PP; Nagashima S; Nishiyama T; Takahashi M; Murata K; Okamoto H
J Virol; 2022 Mar; 96(6):e0190621. PubMed ID: 35107380
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
[TBL] [Abstract][Full Text] [Related]
19. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
[TBL] [Abstract][Full Text] [Related]
20. Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling.
Li Y; Li P; He Q; Zhang R; Li Y; Kamar N; Peppelenbosch MP; de Man RA; Wang L; Pan Q
Antiviral Res; 2022 Jan; 197():105228. PubMed ID: 34929248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
